Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 USD | +3.57% | +10.48% | -17.65% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
Business Summary
Number of employees: 500
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery
100.0
%
| 40 | 100.0 % | 45 | 100.0 % | +11.88% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 40 | 100.0 % | 45 | 100.0 % | +11.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Tina Larson
PSD | President | 49 | 18-06-30 |
Michael Secora
DFI | Director of Finance/CFO | 41 | 20-02-29 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 21-08-15 | |
Benjamin Mabey
CTO | Chief Tech/Sci/R&D Officer | 41 | 17-02-28 |
Laura Schaevitz
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Mauro
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Chairman | 60 | 20-03-31 | |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Zachary Bogue
BRD | Director/Board Member | 48 | 18-07-31 |
Zavain Dar
BRD | Director/Board Member | 35 | 16-08-31 |
Founder | 41 | 13-11-04 | |
Director/Board Member | 47 | 20-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 7,509,871 | 0 | 0 | 91.44 % |
Stock B | 1 | 230,107,332 | 217,267,089 ( 94.42 %) | 0 |
Company contact information
Recursion Pharmaceuticals, Inc.
41 South Rio Grande Street
84101, Salt Lake City
+
http://www.recursion.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.65% | 1.93B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.67% | 22.15B | |
-17.37% | 21.02B | |
-8.42% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RXRX Stock
- Company Recursion Pharmaceuticals, Inc.